Some drug-like compounds can spontaneously self-assemble into nanoparticles under physiological conditions. While these colloidal drug aggregates have traditionally been seen as nuisances in drug screening and formulation, their unique drug-rich nature hints at applications in drug delivery. Unfortunately, colloids get trapped in the endo-lysosomal pathway, reducing efficacy. In my project, I aim to use ionizable colloidal drug aggregates to disrupt endosomal and lysosomal membranes. This strategy will improve drug delivery into the cell.


PhD. student at University of Toronto
Department of Chemical Engineering and Applied Chemistry
Institute of Biomaterials and Biomedical Engineering

Completed BASc. at Queen’s University
Major in Engineering Chemistry


OGS (2019, 2020, 2021)
PRiME Fellowship (2020)
QEII-GSST (2018)

PhD Candidate, 2016 - Present